Endocan: A novel marker of endothelial dysfunction in C1-inhibitor-deficient hereditary angioedema
International Archives of Allergy and Immunology Nov 06, 2017
Demirturk M, et al. - In this study, hereditary angioedema (HAE) patients were scrutinized for levels of endocan and vascular cell adhesion molecules (VCAM) in their peripheral blood samples, with an intent to investigate endothelial activation in attack-free periods. Findings indicated that increased endocan and VCAM-1 levels may reflect an endothelial activation even in attack-free periods in HAE patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries